DK294579A
(da)
|
1978-07-13 |
1980-01-14 |
Wellcome Found |
Antiprotozoelle oxadiazolderivater fremgangsmaade til deres fremstilling samt deres anvendelse
|
EP0036711B1
(en)
|
1980-03-22 |
1985-12-04 |
Fbc Limited |
Pesticidal heterocyclic compounds, processes for preparing them, compositions containing them, and their use
|
US4602093A
(en)
|
1984-02-08 |
1986-07-22 |
Merck & Co., Inc. |
Novel substituted imidazoles, their preparation and use
|
JPS61200544A
(ja)
|
1985-03-04 |
1986-09-05 |
Toyo Ink Mfg Co Ltd |
電子写真感光体
|
DE3600390A1
(de)
|
1986-01-09 |
1987-07-16 |
Hoechst Ag |
Diarylalkyl-substituierte alkylamine, verfahren zu ihrer herstellung, ihre verwendung sowie sie enthaltende arzneimittel
|
EP0264883A3
(en)
|
1986-10-21 |
1990-04-04 |
Banyu Pharmaceutical Co., Ltd. |
Substituted pyridine derivatives
|
JPS63165376A
(ja)
|
1986-12-27 |
1988-07-08 |
Nippon Soda Co Ltd |
オキサ(チア)ジアゾ−ル誘導体その製造方法及び殺ダニ剤
|
JPH01108006A
(ja)
|
1987-10-21 |
1989-04-25 |
Nagasaki Pref Gov |
脆性材料の割断加工方法
|
JPH01110376A
(ja)
|
1987-10-24 |
1989-04-27 |
Mizuno Corp |
繊維強化プラスチックス製バットの製造方法
|
KR910001238B1
(ko)
|
1988-02-26 |
1991-02-26 |
재단법인 한국화학연구소 |
O-아실아미드옥심 유도체
|
EP0338372A3
(en)
|
1988-04-22 |
1991-10-09 |
American Cyanamid Company |
Solubilized pro-drugs
|
CA1340821C
(en)
|
1988-10-06 |
1999-11-16 |
Nobuyuki Fukazawa |
Heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components
|
US5180719A
(en)
|
1988-10-24 |
1993-01-19 |
Norwich Eaton Pharmaceuticals, Inc. |
Antimicrobial quinolonyl lactam esters
|
GB8900382D0
(en)
|
1989-01-09 |
1989-03-08 |
Janssen Pharmaceutica Nv |
2-aminopyrimidinone derivatives
|
ES2087097T3
(es)
|
1989-04-19 |
1996-07-16 |
Otsuka Pharma Co Ltd |
Derivados de acidos fenilcarboxilicos que contienen un heterociclo.
|
GB8908875D0
(en)
|
1989-04-19 |
1989-06-07 |
Ici Plc |
Fungicides
|
JPH0313040A
(ja)
|
1989-06-09 |
1991-01-22 |
Sharp Corp |
コードレス電話機
|
KR910009330B1
(ko)
|
1989-10-23 |
1991-11-11 |
재단법인 한국화학연구소 |
항균작용을 갖는 퀴놀린계 화합물과 그의 제조방법
|
KR910009333B1
(ko)
|
1989-10-23 |
1991-11-11 |
재단법인 한국화학연구소 |
항균작용을 갖는 퀴놀린계 화합물과 그의 제조방법
|
KR910009331B1
(ko)
|
1989-10-23 |
1991-11-11 |
재단법인 한국화학연구소 |
디아자비시클로아민 화합물과 그의 제조방법
|
US5030631A
(en)
|
1989-11-27 |
1991-07-09 |
Schering Corporation |
Tricylclic arylsulfonamides
|
US5747502A
(en)
|
1989-12-13 |
1998-05-05 |
Nippon Kayaku Kabushiki Kaisha |
Process for preparing benzo c!phenanthridinium derivatives, novel compounds prepared by said process, and antitumor agents
|
JP3036789B2
(ja)
|
1990-06-22 |
2000-04-24 |
三井化学株式会社 |
新規な複素環式化合物及び医薬組成物
|
FR2664592B1
(fr)
|
1990-07-10 |
1994-09-02 |
Adir |
Nouveaux derives de la piperidine, de la tetrahydropyridine et de la pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
US5262565A
(en)
|
1990-11-16 |
1993-11-16 |
Eisai Co., Ltd. |
Naphthalene derivatives
|
JP2859451B2
(ja)
|
1991-01-11 |
1999-02-17 |
太平洋セメント株式会社 |
N−フルオロピリジニウム塩の製造方法
|
DE4121214A1
(de)
|
1991-06-27 |
1993-01-14 |
Bayer Ag |
7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate
|
JP3038065B2
(ja)
|
1991-11-07 |
2000-05-08 |
太平洋セメント株式会社 |
N−フルオロピリジニウム塩の製造方法
|
JPH05196976A
(ja)
|
1991-11-18 |
1993-08-06 |
Toshiba Corp |
有機非線形光学材料
|
ES2143992T3
(es)
|
1991-11-25 |
2000-06-01 |
Pfizer |
Derivados de 5-(hetero- o carbociclilamino)-indol, su preparacion y uso como 5-ht1 agonistas.
|
ATE194981T1
(de)
|
1992-04-30 |
2000-08-15 |
Taiho Pharmaceutical Co Ltd |
Oxazolidinderivat und sein pharmazeutisch verträgliches salz
|
DE4232418A1
(de)
|
1992-09-28 |
1994-03-31 |
Bayer Ag |
Verwendung von substituierten 1,2,4-Oxadiazolderivaten zur Bekämpfung von Endoparasiten, neue substituierte 1,2,4-Oxadiazolderivate und Verfahren zu ihrer Herstellung
|
US5262564A
(en)
|
1992-10-30 |
1993-11-16 |
Octamer, Inc. |
Sulfinic acid adducts of organo nitroso compounds useful as retroviral inactivating agents anti-retroviral agents and anti-tumor agents
|
JP3130400B2
(ja)
|
1993-01-13 |
2001-01-31 |
信越化学工業株式会社 |
重合体スケール付着防止剤、及びそれを利用する重合体の製造方法
|
JPH07164400A
(ja)
|
1993-12-15 |
1995-06-27 |
Nec Corp |
ガラス基板の切断装置
|
DE4401108A1
(de)
|
1994-01-17 |
1995-07-20 |
Bayer Ag |
1,2,4-Oxadiazol-Derivate
|
US6878715B1
(en)
|
1994-02-18 |
2005-04-12 |
Cell Therapeutics, Inc. |
Therapeutic compounds for inhibiting interleukin-12 signals and method for using same
|
IT1274018B
(it)
|
1994-02-23 |
1997-07-14 |
Riace Ets |
Derivati del 3,8-diazabiciclo(3.2.1.)ottano ad attivita' analgesica
|
FR2732964B1
(fr)
|
1995-04-14 |
1997-05-16 |
Adir |
Nouveaux amides tricycliques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
|
JP3830183B2
(ja)
|
1995-09-29 |
2006-10-04 |
東京応化工業株式会社 |
オキシムスルホネート化合物及びレジスト用酸発生剤
|
JP3275666B2
(ja)
|
1995-10-18 |
2002-04-15 |
トヨタ自動車株式会社 |
車輌の挙動制御装置
|
DE19608316C2
(de)
|
1996-02-22 |
2000-11-09 |
Ivoclar Ag Schaan |
Funktionalisierte bicyclische (Meth)acrylate, Verfahren zu deren Herstellung und deren Verwendung ####
|
JP2001520685A
(ja)
|
1997-02-28 |
2001-10-30 |
キャンデセント・テクノロジーズ・コーポレイション |
ポリカーボネート含有液体化学調合物及びポリカーボネートフィルムを形成するための方法
|
US6500885B1
(en)
|
1997-02-28 |
2002-12-31 |
Candescent Technologies Corporation |
Polycarbonate-containing liquid chemical formulation and methods for making and using polycarbonate film
|
JP2002501506A
(ja)
|
1997-05-03 |
2002-01-15 |
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー |
ドーパミンd▲下3▼受容体のモジュレーターとしてのテトラヒドロイソキノリン誘導体
|
JPH1110376A
(ja)
|
1997-06-25 |
1999-01-19 |
Souei Tsusho Kk |
割断加工方法
|
WO1999001442A1
(en)
|
1997-07-02 |
1999-01-14 |
Zeneca Limited |
Triazine derivatives and their use as antibacterial agents
|
GB9714383D0
(en)
|
1997-07-08 |
1997-09-10 |
Pfizer Ltd |
Improved process
|
US6100291A
(en)
|
1998-03-16 |
2000-08-08 |
Allelix Biopharmaceuticals Inc. |
Pyrrolidine-indole compounds having 5-HT6 affinity
|
US6020525A
(en)
|
1998-03-19 |
2000-02-01 |
Hoffmann-La Roche Inc. |
(2S,2'R,3'R)-2-(2,3-dicarboxyl-cyclopropyl)-glycine (DCG-1/4) and 3 H-DCG-1/4 and to process for the preparation thereof
|
US6214879B1
(en)
|
1998-03-24 |
2001-04-10 |
Virginia Commonwealth University |
Allosteric inhibitors of pyruvate kinase
|
CA2325689A1
(en)
|
1998-03-26 |
1999-09-30 |
Department Of The Army, U.S. Government |
Substituted aromatic compounds for treatment of antibiotic resistant infections
|
DE19826671A1
(de)
|
1998-06-16 |
1999-12-23 |
Hoechst Schering Agrevo Gmbh |
1,3-Oxazolin- und 1,3-Thiazolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel
|
FR2780057B1
(fr)
|
1998-06-18 |
2002-09-13 |
Sanofi Sa |
Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
|
AUPP466598A0
(en)
|
1998-07-14 |
1998-08-06 |
University Of Newcastle Research Associates Limited, The |
Product and process
|
TWI250152B
(en)
|
1998-07-21 |
2006-03-01 |
Eisai Co Ltd |
N,N-substituted cyclic amine compounds used as calcium antagonizer
|
SK4782001A3
(en)
|
1998-10-08 |
2001-11-06 |
Smithkline Beecham Plc |
Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
|
AU2914200A
(en)
|
1999-03-08 |
2000-09-28 |
Bayer Aktiengesellschaft |
Thiazolyl urea derivatives and their utilization as antiviral agents
|
AU6621600A
(en)
|
1999-08-04 |
2001-03-05 |
Millennium Pharmaceuticals, Inc. |
Melanocortin-4 receptor binding compounds and methods of use thereof
|
EP1096310B1
(en)
|
1999-10-26 |
2004-06-02 |
Fuji Photo Film Co., Ltd. |
Photothermographic material
|
DE19955824A1
(de)
|
1999-11-20 |
2001-06-13 |
Schott Spezialglas Gmbh |
Verfahren und Vorrichtung zum Schneiden eines Werkstückes aus sprödbrüchigem Werkstoff
|
MXPA02004985A
(es)
|
1999-11-26 |
2003-10-14 |
Shionogi & Co |
Antagonistas del neuropeptido y, y5.
|
JP4782342B2
(ja)
|
1999-12-17 |
2011-09-28 |
サノフィ−アベンティス |
フェノキシプロパノールアミン類、それらの製造方法およびそれらを含む医薬組成物
|
HUP0204496A3
(en)
|
2000-01-20 |
2004-07-28 |
Eisai Co Ltd |
Novel piperidine compounds and pharmaceutical compositions containing the same and process for preparation the same
|
US20020025961A1
(en)
|
2000-02-04 |
2002-02-28 |
Scarborough Robert M. |
Platelet ADP receptor inhibitors
|
GB0004886D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
JP2001261653A
(ja)
|
2000-03-17 |
2001-09-26 |
Sankio Chemical Co Ltd |
ピリジン誘導体の合成法
|
WO2001085728A2
(en)
|
2000-05-08 |
2001-11-15 |
Wockhardt Limited |
Antibacterial chiral 8-(substituted piperidino)-benzo [i, j] quinolizines, processes, compositions and methods of treatment
|
EP1578341A2
(en)
|
2000-10-11 |
2005-09-28 |
Tularik Inc. |
Modulation of ccr4 function
|
CA2426706A1
(en)
|
2000-10-26 |
2002-05-02 |
Smithkline Beecham P.L.C. |
Benzoxazinone derivatives, their preparation and use
|
CN101928288B
(zh)
|
2000-11-02 |
2013-09-11 |
斯隆-凯特林癌症研究所 |
结合hsp90的小分子组合物
|
SE0100326D0
(sv)
|
2001-02-02 |
2001-02-02 |
Astrazeneca Ab |
New compounds
|
AUPR392301A0
(en)
|
2001-03-23 |
2001-04-26 |
University Of Newcastle Research Associates Limited, The |
Protein phosphatase inhibitors
|
EP1390525B8
(en)
|
2001-05-23 |
2009-03-04 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Pyruvate-kinase as a novel target molecule
|
DE10139416A1
(de)
|
2001-08-17 |
2003-03-06 |
Aventis Pharma Gmbh |
Aminoalkyl substituierte aromatische Bicyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
US7173032B2
(en)
|
2001-09-21 |
2007-02-06 |
Reddy Us Therapeutics, Inc. |
Methods and compositions of novel triazine compounds
|
JP4397691B2
(ja)
|
2001-10-30 |
2010-01-13 |
コンフォーマ・セラピューティクス・コーポレイション |
Hsp90阻害活性を有するプリン類似体
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
BR0307501A
(pt)
|
2002-02-06 |
2004-12-07 |
Ciba Sc Holding Ag |
Derivados de sulfonato e o uso destes como ácidos latentes
|
US6995144B2
(en)
|
2002-03-14 |
2006-02-07 |
Eisai Co., Ltd. |
Nitrogen containing heterocyclic compounds and medicines containing the same
|
AR040336A1
(es)
|
2002-06-26 |
2005-03-30 |
Glaxo Group Ltd |
Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
|
WO2004007770A2
(en)
|
2002-07-10 |
2004-01-22 |
Oncotherapy Science, Inc. |
Method for diagnosis of intestinal-type gastric tumors
|
TW200403243A
(en)
|
2002-07-18 |
2004-03-01 |
Wyeth Corp |
1-Heterocyclylalkyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands
|
US20060100233A1
(en)
|
2002-07-25 |
2006-05-11 |
Manuela Villa |
Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
JP2005537290A
(ja)
|
2002-07-25 |
2005-12-08 |
ファルマシア・イタリア・エス・ピー・エー |
キナーゼ阻害剤として活性なビシクロピラゾール類、その製造方法、およびそれを含有する薬学的組成物
|
ES2445208T3
(es)
|
2002-07-29 |
2014-02-28 |
Rigel Pharmaceuticals, Inc. |
Compuestos de 2,4-pirimidindiamina para uso en métodos para tratar o prevenir enfermedades autoinmunitarias
|
EP1534666A1
(de)
|
2002-09-06 |
2005-06-01 |
Schebo Biotech AG |
Verbindungen zur modulation des glykolyse-enzym-und/oder transaminase-komplexes
|
JP2004175674A
(ja)
|
2002-11-25 |
2004-06-24 |
Toyo Ink Mfg Co Ltd |
有機エレクトロルミネッセンス素子材料およびそれを使用した有機エレクトロルミネッセンス素子
|
EP1437145A1
(en)
|
2003-01-07 |
2004-07-14 |
Schering AG |
Enhanced scintigraphic imaging agents for imaging of infection and inflammation
|
WO2004072081A1
(en)
|
2003-02-10 |
2004-08-26 |
Cellular Genomics, Inc. |
Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of kinase activity
|
MXPA05009719A
(es)
|
2003-03-11 |
2005-10-18 |
Pharmacia Italia Spa |
Derivados de biciclo-pirazol activos como inhibidores de cinasa, procedimiento para su preparacion y composiciones farmaceuticas que los comprenden.
|
US7449464B2
(en)
|
2003-03-12 |
2008-11-11 |
Kudos Pharmaceuticals Limited |
Phthalazinone derivatives
|
DE10316081A1
(de)
|
2003-04-08 |
2004-10-21 |
Morphochem AG Aktiengesellschaft für kombinatorische Chemie |
Neue Verbindungen mit antibakterieller Aktivität
|
EP1615698B1
(en)
|
2003-04-11 |
2010-09-29 |
High Point Pharmaceuticals, LLC |
New amide derivatives and pharmaceutical use thereof
|
WO2004104000A1
(ja)
|
2003-05-23 |
2004-12-02 |
Japan Tobacco Inc. |
トリサイクリック縮合環化合物およびその医薬用途
|
CA3084542A1
(en)
|
2003-06-10 |
2005-01-06 |
The Trustees Of Boston University |
Gene expression analysis of airway epithelial cells for diagnosing lung cancer
|
EP1643998B1
(en)
|
2003-07-03 |
2007-08-29 |
F. Hoffmann-La Roche Ag |
Dual nk1/nk3 antagonists for treating schizophrenia
|
GB0317484D0
(en)
|
2003-07-25 |
2003-08-27 |
Pfizer Ltd |
Nicotinamide derivatives useful as pde4 inhibitors
|
KR20060036106A
(ko)
|
2003-07-30 |
2006-04-27 |
제논 파마슈티칼스 인크. |
피리딜 유도체 및 그의 치료제로서의 용도
|
EP2316826A1
(en)
|
2003-07-30 |
2011-05-04 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives and their use as therapeutics agents
|
GB0319150D0
(en)
|
2003-08-14 |
2003-09-17 |
Glaxo Group Ltd |
Novel compounds
|
AU2004270733B2
(en)
|
2003-09-11 |
2011-05-19 |
Itherx Pharma, Inc. |
Cytokine inhibitors
|
KR20060070572A
(ko)
|
2003-09-18 |
2006-06-23 |
콘포마 세러퓨틱스 코포레이션 |
Hsp90-저해제로서의 신규 헤테로시클릭 화합물
|
DE10353910A1
(de)
|
2003-11-18 |
2005-06-09 |
Studiengesellschaft Kohle Mbh |
Verfahren zur Synthese optisch aktiver Piperidine
|
AR046771A1
(es)
|
2003-12-18 |
2005-12-21 |
Tibotec Pharm Ltd |
Derivados piperidina-amino-bencimidazol como inhibidores de la replicacion del virus sincitial respiratorio
|
ES2326813T3
(es)
|
2003-12-18 |
2009-10-20 |
Tibotec Pharmaceuticals Ltd. |
Derivados de amino-bencimidazoles como inhibidores de la replicacion del virus respiratorio sincitial.
|
WO2005058874A1
(en)
|
2003-12-18 |
2005-06-30 |
Tibotec Pharmaceuticals Ltd. |
5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
|
US8044073B2
(en)
|
2003-12-18 |
2011-10-25 |
Tibotec Pharmaceuticals |
Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication
|
AR046959A1
(es)
|
2003-12-18 |
2006-01-04 |
Tibotec Pharm Ltd |
Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio
|
EP1564590A3
(en)
|
2004-02-16 |
2007-01-17 |
Fuji Photo Film Co., Ltd. |
Photosensitive composition
|
JP4845873B2
(ja)
|
2004-03-03 |
2011-12-28 |
ケモセントリックス インコーポレーティッド |
二環式および架橋した窒素複素環
|
US7435831B2
(en)
|
2004-03-03 |
2008-10-14 |
Chemocentryx, Inc. |
Bicyclic and bridged nitrogen heterocycles
|
US20070185090A1
(en)
|
2004-03-17 |
2007-08-09 |
Jakob Busch-Petersen |
Muscarinic acetylchoine receptor antagonists
|
WO2005094251A2
(en)
|
2004-03-17 |
2005-10-13 |
Glaxo Group Limited |
M3muscarinic acetylcholine receptor antagonists
|
US7335770B2
(en)
|
2004-03-24 |
2008-02-26 |
Reddy U5 Therapeutics, Inc. |
Triazine compounds and their analogs, compositions, and methods
|
TWI391387B
(zh)
|
2004-05-12 |
2013-04-01 |
Eisai R&D Man Co Ltd |
具有哌啶環之吲哚衍生物
|
WO2006009886A1
(en)
|
2004-06-21 |
2006-01-26 |
Merck & Co., Inc. |
Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
EP1792181B1
(en)
|
2004-06-21 |
2010-11-17 |
Progenra Inc. |
Diagnostic and screening methods and kits associated with proteolytic activity
|
DE102004039789A1
(de)
|
2004-08-16 |
2006-03-02 |
Sanofi-Aventis Deutschland Gmbh |
Arylsubstituierte polycyclische Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
AU2005277389A1
(en)
|
2004-08-18 |
2006-03-02 |
Elixir Pharmaceuticals, Inc. |
Growth-hormone secretagogues
|
DE102004041163A1
(de)
|
2004-08-25 |
2006-03-02 |
Morphochem Aktiengesellschaft für kombinatorische Chemie |
Neue Verbindungen mit antibakterieller Aktivität
|
EP2289510A1
(en)
|
2004-09-20 |
2011-03-02 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
|
US7592343B2
(en)
|
2004-09-20 |
2009-09-22 |
Xenon Pharmaceuticals Inc. |
Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors
|
CN101039935B
(zh)
|
2004-10-05 |
2011-04-20 |
埃科特莱茵药品有限公司 |
哌啶抗生素
|
JP2008521805A
(ja)
|
2004-11-30 |
2008-06-26 |
アーテシアン セラピューティクス, インコーポレイテッド |
β−アドレナリン作用性受容体およびホスホジエステラーゼに対する阻害活性を有する強心性化合物
|
US7968574B2
(en)
|
2004-12-28 |
2011-06-28 |
Kinex Pharmaceuticals, Llc |
Biaryl compositions and methods for modulating a kinase cascade
|
US7834181B2
(en)
|
2005-02-01 |
2010-11-16 |
Slaon-Kettering Institute For Cancer Research |
Small-molecule Hsp90 inhibitors
|
GT200600046A
(es)
|
2005-02-09 |
2006-09-25 |
|
Terapia de combinacion
|
PT1856057E
(pt)
|
2005-02-25 |
2015-02-04 |
Serenex Inc |
Derivados de tetraidroindolona e tetraidroindazolona, sua composição e usos relacionados
|
WO2006099884A1
(en)
|
2005-03-24 |
2006-09-28 |
Actelion Percurex Ag |
Beta-aminoalcohol antibiotics
|
AU2006235022B2
(en)
|
2005-04-07 |
2011-07-21 |
Merck Sharp & Dohme Corp. |
Mitotic kinesin inhibitors
|
GB0510204D0
(en)
|
2005-05-19 |
2005-06-22 |
Chroma Therapeutics Ltd |
Enzyme inhibitors
|
WO2006130469A1
(en)
|
2005-05-27 |
2006-12-07 |
Oregon Health & Science University |
Stimulation of neurite outgrowth by small molecules
|
WO2006137485A1
(ja)
|
2005-06-24 |
2006-12-28 |
Toyama Chemical Co., Ltd. |
新規な含窒素複素環化合物およびその塩
|
GB0514018D0
(en)
|
2005-07-07 |
2005-08-17 |
Ionix Pharmaceuticals Ltd |
Chemical compounds
|
KR20080027832A
(ko)
|
2005-07-11 |
2008-03-28 |
사노피-아벤티스 |
신규의 2,4-디아닐리노피리미딘 유도체, 그의 제법, 및의약으로서, 제약 조성물로서, 특히 ikk 억제제로서의그의 용도
|
AU2006278397B2
(en)
|
2005-08-04 |
2013-01-17 |
Sirtris Pharmaceuticals, Inc. |
Oxazolopyridine derivatives as sirtuin modulators
|
KR20080064953A
(ko)
|
2005-10-13 |
2008-07-10 |
모르포켐 악티엥게셀샤프트 퓌르 콤비나토리셰 케미 |
항균 활성을 갖는 5-퀴놀린 유도체
|
GB0600967D0
(en)
|
2006-01-18 |
2006-03-01 |
Imp Innovations Ltd |
Methods
|
JP5111398B2
(ja)
|
2006-01-25 |
2013-01-09 |
メルク・シャープ・エンド・ドーム・コーポレイション |
糖尿病の治療又は予防のためのジペプチジルペプチダーゼiv阻害剤としてのアミノシクロヘキサン類
|
DK1978947T3
(da)
|
2006-02-03 |
2014-11-03 |
Nicox Science Ireland |
Nitrooxyderivater til anvendelse ved behandling af muskeldystrofier
|
WO2007097931A2
(en)
|
2006-02-15 |
2007-08-30 |
Merck & Co., Inc. |
Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
US7696229B2
(en)
|
2006-02-17 |
2010-04-13 |
Memory Pharmaceuticals Corporation |
Compounds having 5-HT6 receptor affinity
|
JP2007246885A
(ja)
|
2006-02-20 |
2007-09-27 |
Toyo Ink Mfg Co Ltd |
光機能材料
|
TW200806669A
(en)
|
2006-03-28 |
2008-02-01 |
Merck & Co Inc |
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
EP2019677B1
(en)
|
2006-05-16 |
2013-08-14 |
Merck Sharp & Dohme Corp. |
Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
US20090306054A1
(en)
|
2006-05-16 |
2009-12-10 |
Gilead Sciences ,Inc. |
Integrase inhibitors
|
BRPI0712516A2
(pt)
|
2006-05-18 |
2016-08-23 |
Hoffmann La Roche |
compostos, composições farmacêuticas, antagonista receptor de a2b, método para uso terapêutico e/ou tratamento profilático e uso de antagonista receptor de a2b
|
EP2029617A2
(en)
|
2006-05-26 |
2009-03-04 |
Cara Therapeutics, Inc. |
N-oxides of kappa opioid receptor peptides
|
GB0610680D0
(en)
|
2006-05-31 |
2006-07-12 |
Istituto Di Ricerche D Biolog |
Therapeutic compounds
|
JP2007328090A
(ja)
|
2006-06-07 |
2007-12-20 |
Fujifilm Corp |
感光性組成物、感光性フィルム、パターン形成方法、及びプリント基板
|
US10336757B2
(en)
|
2006-06-30 |
2019-07-02 |
Sloan-Kettering Institute For Cancer Research |
Treatment of neurodegenerative diseases through inhibition of HSP90
|
JP2008031064A
(ja)
|
2006-07-27 |
2008-02-14 |
Astellas Pharma Inc |
ジアシルピペラジン誘導体
|
WO2008094203A2
(en)
|
2006-08-03 |
2008-08-07 |
Microbiotix, Inc. |
Polar ester prodrugs of heterocyclic hybrid antibacterial compounds and salts thereof
|
ES2614931T3
(es)
|
2006-08-04 |
2017-06-02 |
Beth Israel Deaconess Medical Center |
Inhibidores de la piruvato cinasa y métodos de tratamiento de enfermedad
|
JP2008063256A
(ja)
|
2006-09-06 |
2008-03-21 |
Astellas Pharma Inc |
β‐アミノ酸誘導体
|
WO2008032905A1
(en)
|
2006-09-13 |
2008-03-20 |
Hurim Biocell Co., Ltd. |
Genes involved in differentiation of human stem cell lines and the microarray kit containing these genes
|
US7875603B2
(en)
|
2006-09-21 |
2011-01-25 |
Nova Southeastern University |
Specific inhibitors for vascular endothelial growth factor receptors
|
TWI454262B
(zh)
*
|
2006-11-02 |
2014-10-01 |
Targacept Inc |
菸鹼乙醯膽鹼受體亞型選擇性之二氮雜雙環烷類醯胺
|
WO2008057608A2
(en)
|
2006-11-10 |
2008-05-15 |
Cara Therapeutics, Inc. |
Synthetic peptide amides
|
FR2910298A1
(fr)
|
2006-12-20 |
2008-06-27 |
Oreal |
Composition tinctoriale contenant une silicone reactive, un colorant fluorescent ou azurant optique, procede de coloration utilisant la composition
|
US8466150B2
(en)
|
2006-12-28 |
2013-06-18 |
Abbott Laboratories |
Inhibitors of poly(ADP-ribose)polymerase
|
MX2009007051A
(es)
|
2006-12-28 |
2009-07-10 |
Abbott Lab |
Inhibidores de la poli(adp-ribosa) polimerasa.
|
KR101313804B1
(ko)
|
2007-03-20 |
2013-10-01 |
쿠리스 인코퍼레이션 |
Hsp90 억제제로서의 융합된 아미노 피리딘
|
WO2008120003A1
(en)
|
2007-04-03 |
2008-10-09 |
Astrazeneca Ab |
Substituted piperidines for use in the treatment of bacterial infections
|
CN101663306A
(zh)
|
2007-04-27 |
2010-03-03 |
塞诺菲-安万特股份有限公司 |
2-杂芳基-吡咯并[3,4-c]吡咯衍生物及其作为scd抑制剂的用途
|
WO2008139585A1
(ja)
|
2007-05-10 |
2008-11-20 |
Toray Engineering Co., Ltd. |
初期亀裂形成機構
|
WO2009001126A1
(en)
|
2007-06-27 |
2008-12-31 |
Astrazeneca Ab |
Substituted piperidine derivatives and their use as antibaterial agents
|
FR2918061B1
(fr)
|
2007-06-28 |
2010-10-22 |
Sanofi Aventis |
Derives de 6-cycloamino-3-(pyridin-4-yl)imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique.
|
US20090023727A1
(en)
|
2007-07-05 |
2009-01-22 |
Muhammad Hashim Javaid |
Phthalazinone derivatives
|
FR2918986B1
(fr)
|
2007-07-19 |
2009-09-04 |
Sanofi Aventis Sa |
Derives de 6-cycloamino-3-(pyridazin-4-yl)imidazo[1,2-b]- pyridazine, leur preparation et leur application en therapeutique
|
EP2019318A1
(en)
|
2007-07-27 |
2009-01-28 |
Erasmus University Medical Center Rotterdam |
Protein markers for cardiovascular events
|
WO2009025781A1
(en)
|
2007-08-16 |
2009-02-26 |
Beth Israel Deaconess Medical Center |
Activators of pyruvate kinase m2 and methods of treating disease
|
WO2009025784A1
(en)
|
2007-08-21 |
2009-02-26 |
Merck & Co., Inc. |
Heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
MX2010005070A
(es)
|
2007-11-15 |
2010-05-24 |
Angeletti P Ist Richerche Bio |
Derivados de piridazinona como inhibidores de parp.
|
US20090291921A1
(en)
|
2007-11-20 |
2009-11-26 |
Gilead Sciences, Inc. |
Integrase inhibitors
|
TW200938203A
(en)
|
2007-12-17 |
2009-09-16 |
Intervet Int Bv |
Anthelmintic agents and their use
|
JP5258280B2
(ja)
|
2007-12-18 |
2013-08-07 |
富士フイルム株式会社 |
顔料分散組成物、感光性樹脂組成物、カラーフィルタおよびその製造方法
|
EP2219646A4
(en)
|
2007-12-21 |
2010-12-22 |
Univ Rochester |
METHOD FOR MODIFYING THE LIFETIME OF EUKARYOTIC ORGANISMS
|
FR2926555B1
(fr)
|
2008-01-22 |
2010-02-19 |
Sanofi Aventis |
Derives bicycliques de carboxamides azabicycliques, leur preparation et leur application en therapeutique
|
UY31603A1
(es)
|
2008-01-23 |
2009-08-31 |
|
Derivados de ftalazinona
|
DE102008010661A1
(de)
|
2008-02-22 |
2009-09-03 |
Dr. Felix Jäger und Dr. Stefan Drinkuth Laborgemeinschaft OHG |
Verfahren zur Herstellung von Pyridin-2-Boronsäure und Derivaten davon
|
JP2009212473A
(ja)
|
2008-03-06 |
2009-09-17 |
Fujifilm Corp |
金属用研磨液、及び化学的機械的研磨方法
|
AU2009231258A1
(en)
|
2008-04-04 |
2009-10-08 |
Biomarin Iga Limited |
Compounds for treating muscular dystrophy
|
KR101538822B1
(ko)
|
2008-05-08 |
2015-07-22 |
노바 사우쓰이스턴 유니버시티 |
혈관 내피 성장 인자 수용체에 대한 특이적 억제제
|
GB0811304D0
(en)
|
2008-06-19 |
2008-07-30 |
Ucb Pharma Sa |
Therapeutic agents
|
US20100022581A1
(en)
|
2008-07-02 |
2010-01-28 |
Memory Pharmaceuticals Corporation |
Pyrrolidine-substituted azaindole compounds having 5-ht6 receptor affinity
|
EP2334680A2
(en)
|
2008-08-20 |
2011-06-22 |
Sequoia Pharmaceuticals, Inc. |
Hcv protease inhibitors
|
US20100144722A1
(en)
|
2008-09-03 |
2010-06-10 |
Dr. Reddy's Laboratories Ltd. |
Novel heterocyclic compounds as gata modulators
|
WO2010028761A1
(de)
*
|
2008-09-09 |
2010-03-18 |
Sanofi-Aventis |
2-heteroaryl-pyrrolo[3, 4-c]pyrrol-derivate und ihre verwendung als scd inhibitoren
|
US8841305B2
(en)
|
2008-10-09 |
2014-09-23 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Activators of the human pyruvate kinase M2 receptor
|
JO2870B1
(en)
|
2008-11-13 |
2015-03-15 |
ميرك شارب اند دوهم كورب |
Amino Tetra Hydro Pirans as Inhibitors of Peptide Dipeptide IV for the Treatment or Prevention of Diabetes
|
CA2741839A1
(en)
|
2008-11-21 |
2010-05-27 |
Pfizer Inc. |
1-oxa-8-azaspiro [4,5] decane-8-carboxamide compounds as faah inhibitors
|
TW201038569A
(en)
|
2009-02-16 |
2010-11-01 |
Abbott Gmbh & Co Kg |
Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
|
JP2010192782A
(ja)
|
2009-02-20 |
2010-09-02 |
Toyo Ink Mfg Co Ltd |
光電変換素子用材料及び光電変換素子
|
US8143244B2
(en)
|
2009-02-26 |
2012-03-27 |
Bristol-Myers Squibb Company |
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
|
US20120121515A1
(en)
|
2009-03-13 |
2012-05-17 |
Lenny Dang |
Methods and compositions for cell-proliferation-related disorders
|
TW201041868A
(en)
|
2009-03-20 |
2010-12-01 |
Intervet Int Bv |
Anthelmintic agents and their use
|
WO2010108268A1
(en)
|
2009-03-23 |
2010-09-30 |
Merck Frosst Canada Ltd. |
Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
WO2010118063A2
(en)
|
2009-04-06 |
2010-10-14 |
Agios Pharmaceuticals, Inc. |
Therapeutic compositions and related methods of use
|
PL2427441T3
(pl)
|
2009-05-04 |
2017-06-30 |
Agios Pharmaceuticals, Inc. |
Aktywatory PKM2 do stosowania w leczeniu raka
|
CN102459251B
(zh)
|
2009-05-14 |
2015-05-20 |
詹森药业有限公司 |
作为白三烯a4水解酶的调节剂的具有两个稠合双环杂芳基部分的化合物
|
WO2010135524A1
(en)
|
2009-05-22 |
2010-11-25 |
Exelixis, Inc. |
Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases
|
WO2010151797A2
(en)
|
2009-06-26 |
2010-12-29 |
University Of Massachusetts |
Compounds for modulating rna binding proteins and uses therefor
|
ES2632954T3
(es)
|
2009-06-29 |
2017-09-18 |
Agios Pharmaceuticals, Inc. |
Derivados de quinolina-8-sulfonamida que tienen una actividad anticancerosa
|
PL2448581T3
(pl)
|
2009-06-29 |
2017-06-30 |
Agios Pharmaceuticals, Inc. |
Kompozycje terapeutyczne i odnośne sposoby ich stosowania
|
WO2012174126A1
(en)
|
2011-06-13 |
2012-12-20 |
Universyty Of Medicine And Dentistry Of New Jesey |
METHOD OF INHIBITING NONSENSE-MEDIATED mRNA DECAY
|
MX353747B
(es)
|
2009-08-17 |
2018-01-26 |
Memorial Sloan Kettering Cancer Center Star |
Compuesto de union a proteina de choque termico, composiciones, y metodos para producir y usar los mismos.
|
US8354403B2
(en)
|
2009-08-27 |
2013-01-15 |
Merck Sharp & Dohme Corp. |
Pyrrolidine derived beta 3 adrenergic receptor agonists
|
WO2011037793A1
(en)
|
2009-09-25 |
2011-03-31 |
Merck Sharp & Dohme Corp. |
Substituted aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
|
WO2011044377A2
(en)
|
2009-10-09 |
2011-04-14 |
Cell Point, Llc |
Chelator-targeting ligand conjugates for cardiovascular imaging
|
CA2793836C
(en)
|
2009-10-21 |
2020-03-24 |
Agios Pharmaceuticals, Inc. |
Methods and compositions for cell-proliferation-related disorders
|
WO2011050210A1
(en)
|
2009-10-21 |
2011-04-28 |
Agios Pharmaceuticals, Inc. |
Methods and compositions for cell-proliferation-related disorders
|
WO2011060321A1
(en)
|
2009-11-16 |
2011-05-19 |
Chdi, Inc. |
Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof
|
KR20160114184A
(ko)
|
2009-11-18 |
2016-10-04 |
미리안트 코포레이션 |
화합물들의 효과적인 생산을 위한 미생물 엔지니어링
|
WO2011103256A1
(en)
|
2010-02-22 |
2011-08-25 |
Merck Sharp & Dohme Corp. |
Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
|
KR20110096442A
(ko)
|
2010-02-22 |
2011-08-30 |
주식회사 이엔에프테크놀로지 |
칼라필터용 착색 감광성 수지 조성물
|
CN101812063B
(zh)
|
2010-03-18 |
2012-04-25 |
中国医学科学院医药生物技术研究所 |
α-萘磺酰胺基五元杂环类化合物及其抑瘤活性
|
US9018227B2
(en)
|
2010-03-19 |
2015-04-28 |
Indiana State University |
Nicotinic acetylcholine receptor agonists
|
UY33288A
(es)
*
|
2010-03-25 |
2011-10-31 |
Glaxosmithkline Llc |
Derivados de indolina inhibidores de la proteina quinasa r del reticulo endoplasmatico
|
CA2797694A1
(en)
|
2010-04-29 |
2011-11-03 |
The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services |
Activators of human pyruvate kinase
|
WO2011146358A1
(en)
|
2010-05-21 |
2011-11-24 |
Merck Sharp & Dohme Corp. |
Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
|
JP2011246649A
(ja)
|
2010-05-28 |
2011-12-08 |
Mitsubishi Chemicals Corp |
顔料分散液、着色樹脂組成物、カラーフィルタ、並びに液晶表示装置及び有機elディスプレイ
|
BR112012033770A2
(pt)
|
2010-06-30 |
2016-11-22 |
Fujifilm Corp |
novo derivado de nicotinamida ou sal do mesmo
|
JP2013532185A
(ja)
|
2010-07-12 |
2013-08-15 |
ファイザー・リミテッド |
化合物
|
JP2013532186A
(ja)
|
2010-07-12 |
2013-08-15 |
ファイザー・リミテッド |
化合物
|
CA2801032A1
(en)
|
2010-07-12 |
2012-01-19 |
Pfizer Limited |
N-sulfonylbenzamide derivatives useful as voltage gated sodium channel inhibitors
|
CN102372716A
(zh)
|
2010-08-09 |
2012-03-14 |
江苏恒瑞医药股份有限公司 |
酞嗪酮类衍生物、其制备方法及其在医药上的应用
|
CN102372706A
(zh)
|
2010-08-09 |
2012-03-14 |
江苏恒瑞医药股份有限公司 |
酞嗪酮类衍生物、其制备方法及其在医药上的应用
|
WO2012056319A1
(en)
|
2010-10-27 |
2012-05-03 |
Dynamix Pharmaceuticals Ltd. |
Sulfonamides for the modulation of pkm2
|
WO2012068096A2
(en)
|
2010-11-15 |
2012-05-24 |
Exelixis, Inc. |
Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture
|
CN103459384A
(zh)
|
2010-11-24 |
2013-12-18 |
埃克塞里艾克西斯公司 |
作为PI3K/mTOR抑制剂的苯并氧氮杂环庚三烯以及它们使用和制造方法
|
JP5699223B2
(ja)
|
2010-12-02 |
2015-04-08 |
シャンハイ デュァ ノボ ファルマテック カンパニー リミテッド |
複素環誘導体、その合成法および医療用途
|
CA2818903C
(en)
|
2010-12-14 |
2021-03-23 |
Electrophoretics Limited |
5-(1,3-benzoxazol-2-yl)-4-(pyridin-4-yl)pyrimidin-2-amine and its use as a casein kinase 1delta inhibitor
|
EP2651898B1
(en)
|
2010-12-17 |
2015-12-09 |
Agios Pharmaceuticals, Inc. |
Novel n-(4-(azetidine-1-carbonyl)phenyl)-(hetero-)arylsulfonamide derivatives as pyruvate kinase m2 (pmk2) modulators
|
MX336022B
(es)
*
|
2010-12-21 |
2016-01-06 |
Agios Pharmaceuticals Inc |
Activadores de pkm2 bicíclicos.
|
TWI549947B
(zh)
|
2010-12-29 |
2016-09-21 |
阿吉歐斯製藥公司 |
治療化合物及組成物
|
KR20230141927A
(ko)
|
2010-12-30 |
2023-10-10 |
파운데이션 메디신 인코포레이티드 |
종양 샘플의 다유전자 분석의 최적화
|
WO2012092485A1
(en)
|
2010-12-31 |
2012-07-05 |
Anthrogenesis Corporation |
Enhancement of placental stem cell potency using modulatory rna molecules
|
JP2012188474A
(ja)
|
2011-03-09 |
2012-10-04 |
Toyo Ink Sc Holdings Co Ltd |
顔料分散剤、それを用いた顔料組成物、着色組成物およびカラーフィルタ
|
JP2012188475A
(ja)
|
2011-03-09 |
2012-10-04 |
Toyo Ink Sc Holdings Co Ltd |
顔料分散剤、それを用いた顔料組成物、着色組成物およびカラーフィルタ
|
CN102206217A
(zh)
|
2011-03-17 |
2011-10-05 |
盛世泰科生物医药技术(苏州)有限公司 |
杂环化合物作为二肽基肽酶抑制剂用于治疗或预防糖尿病
|
WO2012139010A1
(en)
|
2011-04-08 |
2012-10-11 |
University Of Kansas |
Grp94 inhibitors
|
WO2012151440A1
(en)
|
2011-05-03 |
2012-11-08 |
Agios Pharmaceuticals, Inc. |
Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia
|
SG194697A1
(en)
|
2011-05-03 |
2013-12-30 |
Agios Pharmaceuticals Inc |
Pyruvate kinase activators for use in therapy
|
WO2012151448A1
(en)
|
2011-05-03 |
2012-11-08 |
Agios Pharmaceuticals, Inc. |
Pyruvate kinase activators for use in therapy
|
ES2668213T3
(es)
*
|
2011-05-03 |
2018-05-17 |
Agios Pharmaceuticals, Inc. |
Uso de activadores de piruvato quinasa para aumentar la vida útil de los glóbulos rojos de la sangre y tratar la anemia
|
CN103608016A
(zh)
|
2011-05-03 |
2014-02-26 |
安吉奥斯医药品有限公司 |
丙酮酸激酶激活剂在治疗中的用途
|
US20120302609A1
(en)
|
2011-05-25 |
2012-11-29 |
Dynamix Pharmaceuticals Ltd. |
Pyrazolines for the Modulation of PKM2
|
GB201108825D0
(en)
|
2011-05-25 |
2011-07-06 |
Univ Dundee |
Morpholino compounds, uses and methods
|
RU2472794C1
(ru)
|
2011-05-25 |
2013-01-20 |
Федеральное государственное образовательное учреждение высшего профессионального образования Астраханский государственный технический университет (ФГОУ ВПО АГТУ) |
Новые бициклические производные пирролидинов, обладающие антиоксидантной активностью, и способ их получения
|
US8895603B2
(en)
|
2011-06-29 |
2014-11-25 |
Merck Sharp & Dohme Corp. |
Crystalline forms of a dipeptidyl peptidase-IV inhibitor
|
WO2013009657A1
(en)
|
2011-07-08 |
2013-01-17 |
Sloan-Kettering Institute For Cancer Research |
Uses of labeled hsp90 inhibitors
|
JO3611B1
(ar)
|
2011-08-10 |
2020-08-27 |
Janssen Sciences Ireland Uc |
سايكلو بنتا (سي (بيرول 4,3 ثاني هيدرو 1 hمستبدله [8,1] نافثيريدينونات مضادة للجراثيم
|
CN102952139B
(zh)
|
2011-08-30 |
2016-08-10 |
上海药明康德新药开发有限公司 |
反式-3a-氟吡咯烷[3,4-C]并环化合物及其制备方法
|
WO2013038390A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
N-substituted heterocyclyl carboxamides
|
US20140249150A1
(en)
|
2011-10-13 |
2014-09-04 |
Agios Pharmaceuticals, Inc |
Activators of pyruvate kinase m2 and methods of treating disease
|
JP5468056B2
(ja)
|
2011-12-15 |
2014-04-09 |
富士フイルム株式会社 |
電気泳動組成物、マイクロカプセル、及び、電気泳動表示素子
|
ES2790358T3
(es)
|
2011-12-28 |
2020-10-27 |
Global Blood Therapeutics Inc |
Compuestos de heteroaril aldehído sustituido y métodos para su uso en el aumento de la oxigenación tisular
|
PT2797416T
(pt)
|
2011-12-28 |
2017-10-23 |
Global Blood Therapeutics Inc |
Compostos de benzaldeído substituído e métodos para a sua utilização no aumento da oxigenação de tecidos
|
CA2860553C
(en)
|
2012-01-04 |
2016-08-23 |
Pfizer Limited |
N-aminosulfonyl benzamides
|
JP2015083542A
(ja)
|
2012-02-08 |
2015-04-30 |
大日本住友製薬株式会社 |
3位置換プロリン誘導体
|
JP5895583B2
(ja)
|
2012-02-21 |
2016-03-30 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、照明装置および表示装置ならびに有機エレクトロルミネッセンス素子の製造方法
|
ES2656972T3
(es)
|
2012-02-23 |
2018-03-01 |
Vanderbilt University |
Análogos de 5-aminotieno [2,3-c] piridazin-6-carboxamida como moduladores alostéricos positivos del receptor de acetilcolina muscarínico M4
|
SG10201701894SA
(en)
|
2012-03-02 |
2017-05-30 |
Genentech Inc |
Amido-Benzyl Sulfone and Sulfoxide Derivatives
|
JP6399660B2
(ja)
|
2012-04-10 |
2018-10-03 |
ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア |
癌治療用組成物および方法
|
MX2014014234A
(es)
|
2012-05-22 |
2015-05-07 |
Genentech Inc |
Benzamidas n-sustituidas y su uso en el tratamiento del dolor.
|
WO2013184794A2
(en)
|
2012-06-05 |
2013-12-12 |
Cara Therapeutics, Inc. |
Peripheral kappa receptor agonists for reducing pain and inflammation
|
KR101663436B1
(ko)
|
2012-07-06 |
2016-10-06 |
제넨테크, 인크. |
N-치환된 벤즈아미드 및 이의 사용 방법
|
EP2876105A4
(en)
|
2012-07-19 |
2016-01-13 |
Sumitomo Dainippon Pharma Co Ltd |
1- (CYCLOALKYL-CARBONYL) PROLINE DERIVATIVE
|
CN103570722A
(zh)
|
2012-07-19 |
2014-02-12 |
中国科学院上海药物研究所 |
稠环哒嗪酮类化合物及其制备方法和用途
|
EP2874626A4
(en)
|
2012-07-23 |
2016-03-23 |
Merck Sharp & Dohme |
TREATMENT OF DIABETES BY ADMINISTRATION OF DIPEPTIDYL PEPTIDASE-IV INHIBITORS
|
MX367309B
(es)
|
2012-08-10 |
2019-08-14 |
Janssen Sciences Ireland Uc |
Nuevos compuestos antibacterianos.
|
AR092211A1
(es)
|
2012-09-24 |
2015-04-08 |
Merck Patent Ges Mit Beschränkter Haftung |
Derivados de hidropirrolopirrol
|
EP3590940B1
(en)
|
2012-09-25 |
2021-06-09 |
F. Hoffmann-La Roche AG |
Hexahydropyrrolo[3,4-c]pyrrole derivatives and related compounds as autotaxin (atx) inhibitors and as inhibitors of the lysophosphatidic acid (lpa) production for treating e.g. renal diseases
|
DK2909181T3
(da)
|
2012-10-16 |
2017-11-20 |
Tolero Pharmaceuticals Inc |
PKM2-modulatorer og fremgangsmåder til anvendelse deraf
|
TWI500613B
(zh)
|
2012-10-17 |
2015-09-21 |
Cadila Healthcare Ltd |
新穎之雜環化合物
|
US9458132B2
(en)
|
2012-11-08 |
2016-10-04 |
Agios Pharmaceuticals, Inc |
Therapeutic compounds and compositions and their use as PKM2 modulators
|
WO2014100734A1
(en)
|
2012-12-21 |
2014-06-26 |
Epizyme, Inc. |
Prmt5 inhibitors and uses thereof
|
GEP201706691B
(en)
|
2012-12-31 |
2017-06-26 |
Cadila Healthcare Ltd |
Substituted phthalazin-1 (2h)-one derivatives as selecti- ve inhibitors of poly (adp-ribose) polymerase-1
|
EP2951575A4
(en)
|
2013-01-31 |
2016-11-02 |
Caprion Proteomics Inc |
BIOMARKERS OF TYPE 2 DIABETES AND USES THEREOF
|
CA2902207A1
(en)
|
2013-02-21 |
2014-08-28 |
Toma Biosciences, Inc. |
Methods, compositions, and kits for nucleic acid analysis
|
AR095079A1
(es)
|
2013-03-12 |
2015-09-16 |
Hoffmann La Roche |
Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
|
US20140274961A1
(en)
|
2013-03-15 |
2014-09-18 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
MY180206A
(en)
|
2013-03-15 |
2020-11-25 |
Global Blood Therapeutics Inc |
Compounds and uses thereof for the modulation of hemoglobin
|
TW201524952A
(zh)
|
2013-03-15 |
2015-07-01 |
Araxes Pharma Llc |
Kras g12c之共價抑制劑
|
AU2014228822A1
(en)
|
2013-03-15 |
2015-10-01 |
Memorial Sloan-Kettering Cancer Center |
HSP90-targeted cardiac imaging and therapy
|
US9422279B2
(en)
|
2013-03-15 |
2016-08-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
US10266551B2
(en)
|
2013-03-15 |
2019-04-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
US10100043B2
(en)
|
2013-03-15 |
2018-10-16 |
Global Blood Therapeutics, Inc. |
Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
|
WO2014139144A1
(en)
|
2013-03-15 |
2014-09-18 |
Agios Pharmaceuticals, Inc. |
Therapeutic compounds and compositions
|
US9458139B2
(en)
|
2013-03-15 |
2016-10-04 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
US8952171B2
(en)
|
2013-03-15 |
2015-02-10 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
US9802900B2
(en)
|
2013-03-15 |
2017-10-31 |
Global Blood Therapeutics, Inc. |
Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
|
US9604999B2
(en)
|
2013-03-15 |
2017-03-28 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
WO2014172638A2
(en)
|
2013-04-18 |
2014-10-23 |
Brandeis University |
Inhibitors of deubiquitinating proteases
|
CN107417616A
(zh)
|
2013-05-01 |
2017-12-01 |
中央研究院 |
治疗β‑地中海贫血和镰状细胞病的方法和组合物
|
KR102084185B1
(ko)
|
2013-08-29 |
2020-03-04 |
주식회사 대웅제약 |
테트라히드로사이클로펜타피롤 유도체 및 이의 제조방법
|
WO2015036078A1
(de)
|
2013-09-11 |
2015-03-19 |
Merck Patent Gmbh |
Heterocyclische verbindungen
|
CN110372636B
(zh)
|
2013-09-20 |
2023-03-28 |
生物马林药物股份有限公司 |
用于治疗疾病的葡萄糖神经酰胺合成酶抑制剂
|
WO2015048336A2
(en)
|
2013-09-25 |
2015-04-02 |
Institute For Systems Biology |
Markers for amyotrophic lateral sclerosis (als) and presymptomatic alzhimer's disease (psad)
|
WO2015051230A1
(en)
|
2013-10-04 |
2015-04-09 |
Drexel University |
Novel compositions useful for inhibiting hiv-1 infection and methods using same
|
JP2016537316A
(ja)
|
2013-10-10 |
2016-12-01 |
ザ リージェンツ オブ ザ ユニバーシティー オブ ミシガン |
デユビキチナーゼ阻害剤およびその使用方法
|
EA201992707A1
(ru)
|
2013-11-18 |
2020-06-30 |
Глобал Блад Терапьютикс, Инк. |
Соединения и их применения для модуляции гемоглобина
|
CA2931732A1
(en)
|
2013-11-27 |
2015-06-04 |
Genentech, Inc. |
Substituted benzamides and methods of use thereof
|
US20160319367A1
(en)
|
2013-12-17 |
2016-11-03 |
Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis |
Means and methods for typing a breast cancer patient and assigning therapy based on the typing
|
US9248199B2
(en)
|
2014-01-29 |
2016-02-02 |
Global Blood Therapeutics, Inc. |
1:1 adducts of sickle hemoglobin
|
WO2015116061A1
(en)
|
2014-01-29 |
2015-08-06 |
Global Blood Therapeutics, Inc. |
1:1 adducts of sickle hemoglobin
|
JP6366728B2
(ja)
|
2014-02-28 |
2018-08-01 |
コーニング インコーポレイテッド |
ジケトピロロピロール半導体材料、その調製方法およびその使用
|
CN106103446B
(zh)
|
2014-03-26 |
2019-07-30 |
豪夫迈·罗氏有限公司 |
作为自分泌运动因子(atx)和溶血磷脂酸(lpa)生产抑制剂的二环化合物
|
CN105037367A
(zh)
|
2014-04-18 |
2015-11-11 |
四川海思科制药有限公司 |
氨基六元环类衍生物及其在医药上的应用
|
CN105085528A
(zh)
|
2014-05-15 |
2015-11-25 |
成都贝斯凯瑞生物科技有限公司 |
作为二肽基肽酶-iv抑制剂的氨基四氢吡喃衍生物
|
WO2015183173A1
(en)
|
2014-05-28 |
2015-12-03 |
Grafström Roland |
In vitro toxicogenomics for toxicity prediction
|
EP3159344B1
(en)
|
2014-06-17 |
2023-09-20 |
Sichuan Haisco Pharmaceutical Co., Ltd. |
Amino pyranoid ring derivative and composition and use thereof
|
CN105294694B
(zh)
|
2014-06-18 |
2019-01-04 |
四川海思科制药有限公司 |
氨基六元环类衍生物及其在医药上的应用
|
JP2017519801A
(ja)
|
2014-07-11 |
2017-07-20 |
インターベット インターナショナル ベー. フェー. |
犬糸状虫に対する駆虫薬の使用
|
JP2017519802A
(ja)
|
2014-07-11 |
2017-07-20 |
インターベット インターナショナル ベー. フェー. |
犬糸状虫に対する駆虫薬の使用
|
US10017463B2
(en)
|
2014-07-21 |
2018-07-10 |
Brandeis University |
Inhibitors of deubiquitinating proteases
|
US9862725B2
(en)
|
2014-07-21 |
2018-01-09 |
Merck Sharp & Dohme Corp. |
Process for preparing chiral dipeptidyl peptidase-IV inhibitors
|
WO2016022656A1
(en)
|
2014-08-05 |
2016-02-11 |
Wayne State University |
Compositions and methods for treatment of sickle cell disease
|
KR101837565B1
(ko)
|
2014-08-06 |
2018-03-12 |
삼성에스디아이 주식회사 |
유기 화합물, 유기 광전자 소자 및 표시 장치
|
EP3193608A4
(en)
|
2014-09-17 |
2018-05-02 |
Epizyme, Inc. |
Carm1 inhibitors and uses thereof
|
WO2016044650A1
(en)
|
2014-09-17 |
2016-03-24 |
Epizyme, Inc. |
Carm1 inhibitors and uses thereof
|
CA2961499A1
(en)
|
2014-09-17 |
2016-03-24 |
Memorial Sloan Kettering Cancer Center |
Hsp90-targeted inflammation and infection imaging and therapy
|
WO2016046837A1
(en)
*
|
2014-09-22 |
2016-03-31 |
Cadila Healthcare Limited |
An improved process for preparation of pyrrolo[3,4- c] pyrrole compounds and intermediates thereof
|
EP3199181B1
(en)
|
2014-09-22 |
2020-05-06 |
Japan Science and Technology Agency |
Anti-influenza virus agent, and screening method for anti-influenza virus agent
|
MA41841A
(fr)
|
2015-03-30 |
2018-02-06 |
Global Blood Therapeutics Inc |
Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
|
WO2016168647A1
(en)
|
2015-04-17 |
2016-10-20 |
Acetylon Pharmaceuticals Inc. |
Treatment of neuroblastoma with histone deacetylase inhibotrs
|
US10550150B2
(en)
|
2015-05-11 |
2020-02-04 |
Cadila Healthcare Limited |
Short-chain peptides as Kappa (κ) opioid receptors (KOR) agonist
|
WO2016196816A1
(en)
|
2015-06-03 |
2016-12-08 |
The University Of North Carolina At Chapel Hill |
Photoredox-catalyzed direct c-h functionalization of arenes
|
US11234976B2
(en)
|
2015-06-11 |
2022-02-01 |
Agios Pharmaceuticals, Inc. |
Methods of using pyruvate kinase activators
|
WO2017006270A1
(en)
|
2015-07-08 |
2017-01-12 |
University Of Southern California |
Deoxyuridine triphosphatase inhibitors
|
CN105153119B
(zh)
|
2015-09-11 |
2019-01-01 |
广州必贝特医药技术有限公司 |
吡啶嘧啶胺类化合物或吡啶吡啶胺类化合物及其应用
|
WO2017050792A1
(en)
|
2015-09-24 |
2017-03-30 |
F. Hoffmann-La Roche Ag |
Bicyclic compounds as atx inhibitors
|
MA42923A
(fr)
|
2015-09-24 |
2021-04-28 |
Hoffmann La Roche |
Composés bicycliques comme inhibiteurs mixtes de atx/ca
|
CN105254628B
(zh)
|
2015-11-13 |
2017-06-23 |
南京华威医药科技开发有限公司 |
吡唑并吡啶类抗肿瘤化合物及其制备方法和应用
|
CN105348286B
(zh)
|
2015-11-25 |
2018-12-18 |
中山奕安泰医药科技有限公司 |
一种2-甲基磺酰基-2,4,5,6-四氢吡咯[3,4-c]吡唑苯磺酸盐的制备方法
|
WO2017191274A2
(en)
|
2016-05-04 |
2017-11-09 |
Curevac Ag |
Rna encoding a therapeutic protein
|
AR108435A1
(es)
|
2016-05-12 |
2018-08-22 |
Global Blood Therapeutics Inc |
Proceso para sintetizar 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)-piridin-3-il)metoxi)benzaldehído
|
MA44037B1
(fr)
|
2016-06-06 |
2020-03-31 |
Arena Pharm Inc |
Modulateurs du récepteur adrénergique bêta 3 utile dans le traitement ou la prévention de troubles associés à ceux-ci
|
CN110191720A
(zh)
|
2016-09-09 |
2019-08-30 |
Tg治疗有限公司 |
用于治疗血液学癌症的抗-CD20抗体、PI 3激酶-δ抑制剂以及抗-PD-1或抗-PD-L1抗体的组合
|
TWI778983B
(zh)
|
2016-10-12 |
2022-10-01 |
美商全球血液治療公司 |
包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
|
JP7062660B2
(ja)
|
2016-12-14 |
2022-05-06 |
オーボ アカデミー ユニヴァーシティー |
全体的な翻訳の減少に基づくパーキンソン病の診断
|
US9744145B1
(en)
|
2017-01-16 |
2017-08-29 |
Macau University Of Science And Technology |
Methods for treating lung cancer
|
CN109311897B
(zh)
|
2017-03-20 |
2021-07-20 |
福马治疗股份有限公司 |
作为丙酮酸激酶(pkr)活化剂的吡咯并吡咯组合物
|
CN106928222B
(zh)
|
2017-04-25 |
2019-08-23 |
淮阴师范学院 |
一种3-烷基中氮茚衍生物的制备方法
|
CA3072455A1
(en)
|
2017-08-15 |
2019-02-21 |
Agios Pharmaceuticals, Inc. |
Pyruvate kinase modulators and use thereof
|
WO2019099651A1
(en)
|
2017-11-16 |
2019-05-23 |
Agios Pharmaceuticals, Inc. |
Methods of using deuterated pyruvate kinase activators
|
CN111372920B
(zh)
|
2017-11-22 |
2023-10-20 |
安吉奥斯医药品有限公司 |
N-(4-(4-(环丙基甲基)哌嗪-1-羰基)苯基)喹啉-8-磺酰胺的结晶形式
|
MA51015A
(fr)
|
2017-12-06 |
2021-04-21 |
Arena Pharm Inc |
Modulateurs du récepteur adrénergique bêta 3 utile dans le traitement ou la prévention de l'insuffisance cardiaque et de troubles associés à celle-ci
|
US20200129485A1
(en)
|
2018-09-19 |
2020-04-30 |
Forma Therapeutics, Inc. |
Treating sickle cell disease with a pyruvate kinase r activating compound
|
US20230055923A1
(en)
|
2018-09-19 |
2023-02-23 |
Forma Therapeutics, Inc. |
Activating pyruvate kinase r
|
WO2020061252A1
(en)
|
2018-09-19 |
2020-03-26 |
Forma Therapeutics, Inc. |
Inhibiting ubiquitin specific peptidase 9x
|
MX2021003187A
(es)
|
2018-09-19 |
2021-06-23 |
Forma Therapeutics Inc |
Inhibición de la peptidasa específica de ubiquitina 9x.
|
JP7164400B2
(ja)
|
2018-10-30 |
2022-11-01 |
株式会社オカムラ |
天板付什器
|
PT3880654T
(pt)
|
2018-11-19 |
2022-04-08 |
Global Blood Therapeutics Inc |
Compostos de 2-formil-3-hidroxifeniloximetil capazes de modular hemoglobina
|
WO2020191022A1
(en)
|
2019-03-18 |
2020-09-24 |
Forma Therapeutics, Inc. |
Inhibiting ubiquitin specific peptidase 9x
|
CN109912610B
(zh)
|
2019-04-04 |
2020-06-23 |
石家庄诚志永华显示材料有限公司 |
有机化合物及其在制备有机电致发光元件中的应用
|